Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Aug. 04, 2013		Jul. 29, 2012
OPERATING ACTIVITIES
Net (loss) income	$ (35,922)		$ 185,394
Adjustments to reconcile to net cash used by operating activities:
Depreciation and amortization	205,348		67,792
Equity in income of unconsolidated affiliates, net	(3,140)		(1,850)
Deferred taxes	(23,697)		15,906
Stock-based compensation expense	34,478		18,891
Debt modification and extinguishment costs	40,395		0
Changes in operating assets and liabilities:
Trade receivables, net	(14,276)		46,095
Inventories, net	(34,010)		(117,028)
Accounts payable, accrued expenses and deferred revenue	(145,871)		39,893
Prepaid expenses	(28,923)		(8,590)
Employer pension contributions	(30,000)		(7,489)
Other, net	97,659		(31,716)
Net cash provided by operating activities	62,041		207,298
INVESTING ACTIVITIES(1)
Business acquisitions, net of cash acquired	(1,815,329)		0
Purchase of property, plant and equipment	(105,571)		(81,685)
Contingent purchase price payments	(26,734)		(25,749)
Net cash used by investing activities	(1,947,634)	[1]	(107,434)	[1]
FINANCING ACTIVITIES(1)
Net proceeds from revolving credit facilities	346		40,000
Net payments on short-term borrowings	(34,673)		(249)
Repayment of old credit facilities	(900,000)		(89,680)
Repayment of new credit facilities	(181,688)		0
Repayment of Warnaco’s previously outstanding debt	(197,000)		0
Net proceeds from credit facilities	2,993,430		0
Payment of fees associated with issuance of senior notes	(16,257)		0
Net proceeds from settlement of awards under stock plans	24,256		4,377
Excess tax benefits from awards under stock plans	15,091		7,082
Cash dividends	(9,203)		(5,490)
Acquisition of treasury shares	(57,121)		(13,633)
Payments of capital lease obligations	(4,655)		(5,664)
Net cash provided (used) by financing activities	1,632,526	[1]	(63,257)	[1]
Effect of exchange rate changes on cash and cash equivalents	(10,222)		(7,818)
(Decrease) increase in cash and cash equivalents	(263,289)		28,789
Cash and cash equivalents at beginning of period	892,209		233,197
Cash and cash equivalents at end of period	$ 628,920		$ 261,986

[1] See Note 17 for information on noncash investing and financing transactions.